RxDoctor Payments Data

Michael Tran, MD

Psychiatry · Anderson, SCNPI 1952513830

Payments from drug & device makers

$2,967in general payments, 2019–2025

Across 163 payments — averaging $18.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$962
  • AbbVie$391
  • Otsuka America Pharmaceutical, Inc.$375
  • Johnson & Johnson$309
  • Neurocrine Biosciences, Inc.$228
  • E.r. Squibb & Sons, L.L.C.$206
  • plus $496 from 8 others

What the payments were for

  • Food & beverage$2,74492%
  • Education$2238%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,967 in reported general payments places this provider in the 80th percentile of 624 psychiatry providers in South Carolina.

See all psychiatry providers in South Carolina

Medicare billing

Part B allowed, 2024
$33,084
Medicare patients
53
Services billed
342

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega TrinzaPaliperidone Palmitate20$151,552
Invega SustennaPaliperidone Palmitate44$111,321
RexultiBrexpiprazole30$44,670
UzedyRisperidone12$38,497
VraylarCariprazine Hcl21$31,234
Abilify MaintenaAripiprazole14$30,804
Clozapine OdtClozapine11$23,544
Duloxetine Hcl93$4,935
Paliperidone ErPaliperidone34$3,269
Divalproex Sodium ErDivalproex Sodium55$2,531
Haloperidol94$2,407
Benztropine Mesylate210$2,328
Quetiapine Fumarate239$1,801
Aripiprazole69$1,767
Olanzapine107$1,535

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Trinza, Invega Sustenna$309$262,87364 claims
Otsuka America Pharmaceutical, Inc.Rexulti, Abilify Maintena$375$75,47544 claims
Teva Pharmaceuticals USA, Inc.Uzedy$962$38,49712 claims
AbbVieVraylar$391$31,23421 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 624 psychiatry providers in South Carolina.

Other psychiatry in Anderson

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →